These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2569998)

  • 21. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis.
    Gibbs TG; McDonnell KA; Stokes T; Graham AA
    Br J Clin Pract; 1989 Jan; 43(1):11-4. PubMed ID: 2574054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
    Salisbury J; Bor S; Blair C
    Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
    [No Abstract]   [Full Text] [Related]  

  • 23. Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
    Allergy; 1989 Sep; 44(7):447-52. PubMed ID: 2573286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with acrivastine--a new antihistamine.
    J Int Med Res; 1989; 17 Suppl 2():1B-68B. PubMed ID: 2569994
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
    Honsinger RW; Thomsen RJ
    Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
    Sussman G; Jancelewicz Z
    Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study.
    Bleehen SS; Thomas SE; Greaves MW; Newton J; Kennedy CT; Hindley F; Marks R; Hazell M; Rowell NR; Fairiss GM
    Br J Dermatol; 1987 Jul; 117(1):81-8. PubMed ID: 3307890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
    Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of efficacy and tolerability of terfenadine administered once daily versus twice daily in patients with chronic idiopathic urticaria.
    Paul E; Reinel D; Ulrich R; Köhler ME
    Ann Allergy; 1989 Oct; 63(4):340-2. PubMed ID: 2572189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time of onset of action of acrivastine in the skin of pollen-allergic subjects. A double-blind, randomized, placebo-controlled comparative study.
    Petersen LJ; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Allergy; 1994 Jan; 49(1):27-30. PubMed ID: 7911009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
    Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
    Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers.
    Rolan PE; Adams J; Posner J
    J Int Med Res; 1989; 17 Suppl 2():35B-39B. PubMed ID: 2570000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of whole season hay fever symptomatology: a comparison of terfenadine with chlorpheniramine.
    Backhouse CI; Rosenberg R
    Br J Clin Pract; 1987 Nov; 41(11):995-9. PubMed ID: 2904272
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of effect of H2 blockade in chronic urticaria [proceedings].
    Cook J; Shuster S
    Br J Dermatol; 1979 Jul; 101 Suppl 17():21-2. PubMed ID: 380624
    [No Abstract]   [Full Text] [Related]  

  • 39. A placebo-controlled comparative study of Dimotane LA against Optimine in the treatment of chronic urticaria with or without dermographism.
    Sim-Davis D; Templeton JS
    Br J Clin Pract; 1983; 37(7-8):253-8. PubMed ID: 6136296
    [No Abstract]   [Full Text] [Related]  

  • 40. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria.
    Grant JA; Bernstein DI; Buckley CE; Chu T; Fox RW; Rocklin RE; Schoenwetter WF; Spector SL; Stafford CT; Stroh JE
    J Allergy Clin Immunol; 1988 Mar; 81(3):574-9. PubMed ID: 3126220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.